| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $83M | ||
| $63M |
Buys | $34,374 | 4 | 100 |
Sells | $0 | 0 | 0 |
| DOW GEOFFREY S | President and CEO | 3 | $19,964 | 0 | $0 | $19,964 |
| XU CHERYL | director | 1 | $14,410 | 0 | $0 | $14,410 |
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia.
Over the last 12 months, insiders at 60 Degrees Pharmaceuticals, Inc. have bought $34,374 and sold $0 worth of 60 Degrees Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at 60 Degrees Pharmaceuticals, Inc. have bought $80,198 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: DOW GEOFFREY S (President and CEO) — $19,964. XU CHERYL (director) — $14,410.
The last purchase of 9,670 shares for transaction amount of $7,759 was made by DOW GEOFFREY S (President and CEO) on 2025‑12‑15.
| 2025-12-15 | DOW GEOFFREY S | President and CEO | 9,670 0.2933% | $0.80 | $7,759 | -27.59% | ||
| 2025-12-11 | DOW GEOFFREY S | President and CEO | 3,613 0.1177% | $0.92 | $3,318 | -31.00% | ||
| 2025-12-10 | DOW GEOFFREY S | President and CEO | 9,350 0.2849% | $0.95 | $8,886 | -35.11% | ||
| 2025-06-03 | XU CHERYL | director | 5,000 0.3362% | $2.88 | $14,410 | -56.36% | ||
| 2024-12-16 | XU CHERYL | director | 2,000 0.0839% | $1.45 | $2,900 | -75.50% | ||
| 2024-12-13 | XU CHERYL | director | 6,000 0.2885% | $1.56 | $9,375 | -73.62% | ||
| 2024-12-12 | XU CHERYL | director | 5,000 0.2453% | $1.82 | $9,125 | -77.33% | ||
| 2024-12-09 | DOW GEOFFREY S | President and CEO | 35,823 1.437% | $1.27 | $45,563 | -74.00% | ||
| 2024-12-06 | DOW GEOFFREY S | President and CEO | 20,579 0.8725% | $1.20 | $24,672 | -67.13% | ||
| 2024-12-05 | DOW GEOFFREY S | President and CEO | 17,549 0.7539% | $1.11 | $19,520 | -68.24% | ||
| 2024-11-21 | DOW GEOFFREY S | President and CEO | 3,500 0.1312% | $0.91 | $3,195 | -52.63% | ||
| 2024-11-20 | DOW GEOFFREY S | President and CEO | 1,000 0.038% | $0.92 | $924 | -54.46% | ||
| 2024-11-19 | DOW GEOFFREY S | President and CEO | 2,500 0.0923% | $0.90 | $2,248 | -53.59% | ||
| 2024-08-27 | XU CHERYL | director | 5,000 0.349% | $1.70 | $8,500 | -65.18% |
| DOW GEOFFREY S | President and CEO | 59618 7.3917% | $103,735.32 | 9 | 0 | <0.0001% |
| XU CHERYL | director | 15816 1.9609% | $27,519.84 | 5 | 0 | <0.0001% |
$1,848,072 | 66 | -14.67% | $2.16M | |
$13,677,131 | 44 | -70.32% | $2.83M | |
$1,138,733 | 28 | -4.94% | $2.8M | |
$377,105 | 24 | -39.28% | $1.76M | |
$8,079,884 | 14 | -43.20% | $703,556.00 | |
$684,058 | 11 | -57.59% | $3.38M | |
$82,890 | 11 | -16.71% | $1.18M | |
$389,864 | 11 | 12.52% | $3.08M | |
$18,269 | 10 | -21.15% | $3.33M | |
60 Degrees Pharmaceuticals, Inc. (SXTP) | $126,023 | 10 | -66.17% | $1.4M |
$90,087 | 9 | 20.06% | $3.35M | |
$7,663,154 | 8 | -48.97% | $1.62M | |
$70,828 | 6 | -57.96% | $1.17M | |
$149,778 | 4 | -45.16% | $3.24M | |
$726,438 | 4 | -72.85% | $1.24M | |
$157,740 | 3 | 153.95% | $2.88M | |
$1,049,630 | 1 | -74.91% | $824,684.00 | |
$23,454 | 1 | -99.16% | $1,425.00 | |
$37,000 | 1 | 79.42% | $2.69M |
| Increased Positions | 3 | +37.5% | 6,791 | +63.77% |
| Decreased Positions | 2 | -25% | 6,350 | -59.63% |
| New Positions | 2 | New | 5,891 | New |
| Sold Out Positions | 2 | Sold Out | 6,350 | Sold Out |
| Total Postitions | 9 | +12.5% | 11,090 | +4.14% |
| Drw Securities, Llc | $13.00 | 0.63% | 25,211 | +25,211 | New | 2025-09-30 |
| Geode Capital Management, Llc | $6.00 | 0.31% | 12,449 | -67 | -0.54% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $2.00 | 0.08% | 3,140 | +542 | +20.86% | 2025-09-30 |
| Ubs Group Ag | $1.00 | 0.04% | 1,476 | +1,462 | +10,442.86% | 2025-09-30 |
| Citigroup Inc | $0 | 0.01% | 189 | +189 | New | 2025-09-30 |
| Osaic Holdings, Inc. | $0 | <0.01% | 100 | 0 | 0% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | <0.01% | 30 | +17 | +130.77% | 2025-09-30 |
| Safe Harbor Fiduciary, Llc | $0 | 0% | 0 | -275 | Sold Out | 2025-06-30 |